Anti-SIRPa/CD172a Antibody (Hospital for Sick Children patent anti-SIRPA)
Catalog No.
F1199
Anti-SIRPa/CD172a Antibody (Hospital for Sick Children patent anti-SIRPA)
Featured Products
Anti-SIRPa / CD172a is an immunoglobulin G1 (IgG1) monoclonal antibody against human signal regulatory protein alpha (SIRPa; CD172a) with potential immune checkpoint inhibition, phagocytosis induction, and anti-tumor activities. Molecular weight: 147.06 kD.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Hospital for Sick Children patent anti-SIRPA
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P78324
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human SIRPα V1 FC at 4 ug/mL can bind Hospital for Sick Children patent anti-SIRPA
SIRPa / CD172a
Please avoid freeze-thaw cycles.